¼¼°èÀÇ Ç÷¾×¾Ï Áø´Ü ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)
Blood Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
»óǰÄÚµå : 1621655
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 155 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç÷¾×¾Ï Áø´Ü ¼¼°è ½ÃÀåÀº 2023³â¿¡ 124¾ï ´Þ·¯·Î Æò°¡µÇ¾î 2024-2032³â¿¡ °ÉÃÄ CAGR 6.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ¼¼°è Ç÷¾×¾ÏÀÇ ÀÌȯÀ²ÀÇ »ó½ÂÀÔ´Ï´Ù. ¹éÇ÷º´, ¸²ÇÁÁ¾, °ñ¼öÁ¾ µîÀÇ Áø´ÜÀ» ¹Þ´Â »ç¶÷ÀÌ ´Ã¾î³²¿¡ µû¶ó, È¿°úÀûÀÎ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ȯ°æÀÇ ¿µÇâ µî ¿©·¯ ¿äÀο¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù.

Ç÷¾×¾Ï Áø´Ü½ÃÀåÀº ºÐÀÚ°Ë»ç, Ç÷¾×°Ë»ç, ¿µ»ó°Ë»ç, »ý°Ë µîÀÇ °Ë»çÀ¯Çüº°·Î ±¸ºÐµË´Ï´Ù. °Ë»ç´Â ÇÕ¸®ÀûÀÎ °¡°Ý°ú ½Å¼ÓÇÑ ³³±â·Î Ç÷¾× ¾ÏÀÇ Á¶±â ¹ß°ß°ú ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϸç ÀÇ·á Á¾»çÀÚµé »çÀÌ¿¡¼­ ¼±È£µË´Ï´Ù. °Ô´Ù°¡ ½ÃÀåÀº ÃÖÁ¾ ¿ëµµº°·Î ºÐ·ùµÇ¾î º´¿ø, Áø´Ü½ÇÇè½Ç, ¾Ï¿¬±¸±â°ü µîÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ±×·¯¸é Ç÷¾×¾Ï °ËÃâÀÇ Á¤¹Ðµµ¿Í ¼Óµµ¸¦ ³ôÀ̱â À§ÇØ ¼±ÁøÀû Áø´Ü ±â¼úÀ» µµÀÔÇÏ´Â °æÇâÀÌ °­ÇØÁö°í ÀÖ½À´Ï´Ù.

ÀÌ Æ®·»µå¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ´Â °ÍÀº ÃÖ÷´Ü Áø´Ü Àåºñ¿¡ ´ëÇÑ ¸¹Àº ÅõÀÚ¿Í Á¶±â ¹ß°ß°ú °³ÀÎÈ­ Ä¡·á Àü·«ÀÇ Áß½ÃÀÔ´Ï´Ù. ¿©·¯ Áø·á°ú¿¡ °ÉÄ¡´Â Á¦ÈÞ Äɾ ÃËÁøÇØ, Ç÷¾×¾Ï Áø´Ü¿¡ À־ÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑÃþ ´õ È®°íÇÑ °ÍÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº ȯÀÚÀÇ »ýÁ¸À²À» Çâ»ó½Ã۰í, Áø´Ü °Ë»ç ¹× ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí, Áö¿ª ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ³â 2023³â
¿¹Ãø³â 2024-2032³â
½ÃÀÛ±Ý¾× 124¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 222¾ï ´Þ·¯
CAGR 6.8%

¶ÇÇÑ, Ç÷¾×¾Ï Áø´Ü ¹× Ä¡·á¸¦ Áö¿øÇÏ´Â ÀÎÇÁ¶ó¸¦ °­È­Çϱâ À§ÇÑ °ø°øÅõÀÚ¿Í ¹Î°£ÅõÀÚ ¸ðµÎ ÀÌ ºÎ¹®ÀÇ ¼öÀͼºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå »ê¾÷ ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Á¦Ç°º°, 2021-2032³â

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : °Ë»ç À¯Çüº°, 2021-2032³â

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¾Ï À¯Çüº°, 2021-2032³â

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

Á¦9Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Blood Cancer Diagnostics Market was valued at USD 12.4 billion in 2023 and is projected to grow at a CAGR of 6.8% between 2024 and 2032. Blood cancer diagnostics encompasses various tests and procedures designed to diagnose, detect, and monitor cancers affecting the bone marrow, blood, and lymphatic system. One of the primary drivers of market growth is the rising incidence of blood cancers worldwide. As more individuals receive diagnoses for conditions like leukemia, lymphoma, and myeloma, the demand for effective diagnostic tools has surged. This increase in prevalence can be attributed to several factors, including an aging population, genetic predispositions, and environmental influences.

The blood cancer diagnostics market is segmented by test type, including molecular tests, blood tests, imaging tests, and biopsies. Blood tests represent a substantial portion of the market, accounting for around USD 4.7 billion in 2023. These tests are a cornerstone in the early detection and monitoring of blood cancers due to their affordability and quick turnaround time, making them a favored option among healthcare professionals. Additionally, the market is categorized by end-use, comprising hospitals, diagnostic laboratories, imaging centers, and cancer research institutes. The hospital segment is expected to reach USD 9 billion by 2032. Hospitals are increasingly incorporating advanced diagnostic technologies to enhance the precision and speed of blood cancer detection.

This trend is fueled by significant investments in cutting-edge diagnostic equipment and a strong focus on early detection and personalized treatment strategies. The integrated healthcare systems found in hospitals facilitate efficient patient management and coordinated care across multiple departments, further solidifying their crucial role in blood cancer diagnostics. In the United States, the blood cancer diagnostics market is anticipated to grow to approximately USD 9.4 billion by 2032. There is a notable emphasis on early detection and prevention of blood cancers, with healthcare providers and government entities advocating for routine screenings and early diagnoses. This proactive approach improves patient survival rates while driving demand for diagnostic tests and technologies, boosting the regional market growth.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$12.4 Billion
Forecast Value$22.2 Billion
CAGR6.8%

Furthermore, both public and private investments to enhance the infrastructure to support blood cancer diagnosis and treatment contribute significantly to revenue growth in this sector.

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Cancer Type, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â